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DiabetesBackground: CYP27B1 gene codes for 25-hydroxyvitamin D3 1-a-hydroxylase, an enzyme that catalyses
the activation of vitamin D to the 1-a, 25 dihydroxyvitamin D3. The activity of this enzyme is altered by
non-synonymous single nucleotide polymorphisms (nsSNPs) located within its gene. Such alterations
consequently affect the synthesis of the active form of the hormone, 1-a, 25 dihydroxyvitamin D3, result-
ing in vitamin D deficiency or insufficiency.
Objective: We aimed to investigate the impact of nsSNPs in the CYP27B1 gene on the structure and/or
function of 25-hydroxyvitamin D3 1-a-hydroxylase.
Methods: The pathogenic nsSNPs in the human CYP27B1 obtained from National Centre for
Biotechnology Information (NCBI) were analysed for their structural and functional consequence using
mutation analysis algorithms like Consurf, I-Mutant, and MutPred. The effects of the mutation on tertiary
structure of the human CYP27B1 protein was predicted using SWISS-MODEL while STRING was used to
investigate its protein–protein interaction.
Results: Out of 938 SNPs in the human CYP27B1 gene, 455 that are responsible for missense mutations in
the protein were subjected to various prediction algorithms to identify the pathogenic variants. Out of 24
consensus pathogenic nsSNPs, our Consurf analysis showed that mutations at conserved positions T321,
R389 and G125 will significantly alter the structure of human CYP27B1 protein. These mutations also
alter the metal binding and result in intrinsic structural disorder. These consequently, alter the 3D struc-
ture of the protein and could impact its ability to interact with other proteins like Cytochrome P450, fam-
ily 2, subfamily R, polypeptide 1; Cytochrome P450, family 24, subfamily A, polypeptide 1 and Vitamin D
receptor, that are involved in vitamin D pathway, as revealed by STRING.
Conclusion: These nsSNPs could contribute to vitamin D deficiency and its associated pathological
conditions.
 2018 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Single nucleotide polymorphisms (SNPs) are regarded as one of
the most common genetic variations in the human genome. They
represent a single base change in a DNA sequence, with a common
substitute of two possible nucleotides at a given position. The non-
synonymous SNPs (nsSNPs) trigger genomic disparities within
protein-coding areas resulting in mutations that could alter the
structure and/or function of the protein. Nonetheless, such struc-
tural and/or functional modifications due to nsSNPs are not dam-
aging or deleterious in most cases [1]. Non-synonymous SNPs
could either alter the structural properties or the function of theprotein. Such alterations may result in disease phenotypes. How-
ever, SNPs in genes involved in regulating key enzymes of nutrient
metabolism may have significant phenotypic outcomes.
One of such enzymes is 25-hydroxyvitamin D3 1-a-hydroxylase
and its gene, cytochrome p450 27B1 (CYP27B1) in humans is sited
on 12q14.1 (Fig. 1). This is the long (q) arm of chromosome 12 at
position 14.1 that also encodes enzymes which belong to the cyto-
chrome P450 superfamily. Generally, cytochrome P450 proteins
are monooxygenases with catalytic activities including xenobiotic
metabolism and synthesis of steroids and other lipids [2]. The pro-
tein encoded by human CYP27B1 is called 25-hydroxyvitamin D3
1-a-hydroxylase and it hydroxylates 25-hydroxyvitamin D3 at
the 1-a position. It is localized in the inner mitochondrial mem-
brane where it converts 25-hydroxyvitamin D3 to the active form
1-a, 25 dihydroxyvitamin D3 [3,4]. The active form of vitamin D3
then binds to the vitamin D receptor to elicit its biological
Fig. 1. CYP27B1 Gene on chromosome 12: bands according to Ensembl, locations according to GeneLoc [38].
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activation and biological activity of the hormone form of vitamin
D, which involves calcium metabolism, cell proliferation and dif-
ferentiation, and immunomodulatory functions, as well as calcidiol
1-monooxygenase activity. However, mutations in the CYP27B1
gene are one of the genomic factors that influence the levels of
active vitamin D in circulation. Vitamin D insufficiency and/or defi-
ciency is linked to rickets and a plethora of several chronic disor-
ders, including Addison’s disease, diabetes, cardiac health, and
cancer [5,6].
In view of the major effects of circulating vitamin D, there is a
consensus that the amount of active vitamin D available to bind
vitamin D receptor is reduced by certain SNPs present in the
CYP27B1 gene.
1.1. Aim
The aim of this study was to elucidate the impact of nsSNPs on
the structural and functional properties of human CYP27B1.2. Materials and methods
2.1. Sequence recovery
The nucleotide sequence data on human CYP27B1 gene was
extracted from the National Centre for Biotechnology Information
(NCBI) while the amino acid sequence of human CYP27B1 protein
in FASTA format was retrieved from UniProt (http://www.uniprot.
org/) [1].
2.2. Retrieval, mining and mapping of SNPs in human CYP27B1
Several databases were used in collecting the polymorphism
data for the human CYP27B1 gene. The databases include: UniProt
database (http://www.uniprot.org), NCBI dbSNP database (https://
www.ncbi.nlm.nih.gov/SNP/), and Ensembl genome browser
(http://www.ensembl.org/index.html) [7]. The SNPs recovered
from these databases were grouped into several functional classes,
as described by Dakal et al. [1].
2.3. Analysis of nsSNP in human CYP27B1
A number of in silico algorithms were used in predicting func-
tional effects of the nsSNPs in human CYP27B1 [8]. These included:
PolyPhen-2 (http://genetics.bwh.harvard.edu/), SIFT (http://sift.
jcvi.org/) and PROVEAN (Protein Variation Effect Analyzer)
(http://provean.jcvi.org). nsSNPAnalyzer (http://snpanalyzer.
uthsc.edu) was used to predict nsSNPs that confer pathogenic
effects and were considered as high-risk nsSNPs for further studies
[9].
2.4. Evolutionary phylogenetic analysis of human CYP27B1 protein
The amino acid evolutionary conservation in CYP27B1 protein
was predicted using the ConSurf web server (consurf.tau.ac.il/)
[10]. ConSurf server uses an empirical Bayesian method for the
determination of evolutionary conservation plus identification ofputative structural and functional residues. The conservation score
of 1–4 is considered as variable, 5–6 as intermediate, and 7–9 as
conserved amino acid position [11,12].
2.5. Extrapolation of amino acid changes and disease phenotypes
The online server used for predicting the molecular basis of the
disease linked amino acid replacement in a mutant protein is
MutPred (http://mutpred.mutdb.org/)[13]. It uses several attri-
butes associated with protein structure, function, and evolution.
Its accuracy of prediction is increased by combining three servers,
SIFT [9], PSI-BLAST [14], and Pfam, profiles alongside TMHMM,
MARCOIL which are structural disorder prediction algorithms and
DisProt.
2.6. Stability analysis of human CYP27B1 protein
I-Mutant adaptation 2.0, which is an internet support vector
dependent upon ProTherm databases, helped to evaluate nsSNP
prompted adjustments in protein dependability [15]. I-Mutant
estimates the free energy changes value (DDG) as a difference
between the unfolding Gibbs free energy value (DG) for the wild
type protein and that of the mutant protein (DDG or DDG = DG
mutant – DG wild type). Potential (surge or reduction) in free
energy change rate (DDG) is also predicted, along with a reliability
index (RI) for the results, where the lowest and highest reliability
are 0 and 10, respectively [16].
2.7. Prediction of post translational modification sites for CYB27B1
The post translational modifications sites within the amino acid
sequence of human CYP27B1 protein was identified using a web
based tool called ModPred (www.modpred.org/) [17].
2.8. Prediction of structural effect of point mutation on human
CYB27B1 protein
Project HOPE (www.cmbi.ru.nl/hope/) was used to identify the
structural effect certain point mutations in the human CYP27B1
protein sequence. A BLAST was initially performed by the algo-
rithm against UniProt and PDB to retrieve tertiary structure infor-
mation and generate a homology model. This was followed by a
prediction of the protein features using the Distributed Annotation
System server [18].
2.9. Prediction of secondary structure and 3D structure of CYP27B1
Protein secondary structures was predicted based on their
specific matrices using the PSIPRED tool (http://bioinf.cs.ucl.ac.
uk/psipred/), with matrices developed by PSI-BLAST [14]. Since
there was no crystal structure of human CYP27B1 protein available
in protein databank, we modelled its 3D structure using SWISS-
MODEL (https://swissmodel.expasy.org/) [19]. SWISS-MODEL is a
fully automated server for predicting 3D structure of proteins using
the crystal structure of similar protein as template. For this pur-
pose, we used rat mitochondrial 1,25-dihydroxyvitamin D3 24-
hydroxylase (pdb ID: 3k9v.2.A) as template.
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Protein-protein interactions are very vital in the assessment of
all protein functional interactions present within the cell. The
search tool for the retrieval of interacting genes/proteins (STRING)
(https://string-db.org/) was used to predict the interaction of
human CYP27B1 protein with other proteins. The STRING gener-
ates protein-protein interaction through, either direct or indirect,
associations between a known protein and other proteins by utiliz-
ing its database of 5,214,234 proteins of 1113 organisms [20]. For
this study, CYP27B1 and Homo sapiens were used as the input.Table 3
CYP27B1 nsSNPs projected to be functionally noteworthy by SNPs estimation
algorithms.
nsSNP ID Mutation SNP Type # Del. Pred.
Rs1057520815 G73E Non-synonymous 2
G102E
Rs118204007 T86R Non-synonymous 2
T321R
Rs118204008 T409I Non-synonymous 1
Rs118204010 R154C Non-synonymous 2
R389C3. Results and discussion
3.1. SNP dataset
In this study, we used extensive computational techniques to
screen for functional genetic variants within the coding region of
human CYP27B1. In total, 938 SNPs were recorded in human
CYP27B1 gene sequence. All the reported SNPs of CYP27B1 gene
were recovered from NCBI dbSNP, Ensembl genome browser, and
the UniProt. In the Ensemble dbSNP database, 456 rsIDs were
mapped that were connected with SNPs in the coding area, but
the present investigation concentrates on SNPs that confer single
amino acid changes into human CYP27B1 protein. The SNPs were
arranged based on their functional classes and are reported in
Table 1.
However, to ascertain whether an assumed missense mutation
affected CYP27B1 function, 441 nsSNPs were subjected to a multi-
plicity of in silico SNP prediction algorithms. A summary of the out-
comes is presented in Table 2.Table 1
Functional consequence types of SNPs present in the human CYP27B1 gene.
Consequence type Count





Missense variant  splice region variant 14
Splice region variant  coding sequence variant 6





Data derived from Ensembl [38].
Table 2
Summary of prediction results for nsSNPs in the CYP27B1 protein.
Prediction Number of nsSNPs (%)
Poly-Phen 2 SIFT nsSNPAnalyzer
Benign 222 (49%)
Possibly damaging 82 (18%)
Probably damaging 134 (29%)
Neutral 17 (4%)
Deleterious 197 (43%)
Deleterious – low confidence 11 (2.5%)
Tolerated 236 (52%)
Tolerated – low confidence 11 (2.5%)
Likely pathogenic 4 (0.9%)
Pathogenic 24 (5.3%)
Uncertain significance 16 (3.5%)
Blank 411 (90.3%)
Data derived from Poly-Phen 2, SIFT and nsSNPAnalyzer [9].In general, nsSNPs are known to modify protein conformation,
interaction, and function. Previous studies have shown that the
SNP of CYP27B1 is one of the factors responsible for low level of
circulating 1-a, 25-dihydroxyvitamin D3 and with correlative rela-
tionship to increased risk of cancer, Addison’s disease and diabetes
[21–23]. Hence, it is important to investigate the potential of each
nsSNP in human CYP27B1 in distorting the structure and function
of 25-hydroxyvitamin D3 1-a-hydroxylase.3.2. Analysis of nsSNP in human CYP27B1
We progressed further to utilizing three in silico SNP prediction
algorithms: PolyPhen-2, SIFT, nsSNPs Analyzer. With regards to the
PolyPhen-2 results, 134 nsSNPs (29%) exist as ‘probably damaging’
to CYP27B1 protein function, while 222 nsSNPs (49%) are benign.
Also, 82 nsSNPs (18%) have ‘possibly damaging’ potential as pre-
dicted by PolyPhen-2 (Table 2). Our SIFT analysis projected that
197 nsSNPs (43%) had deleterious effects to CYP27B1protein func-
tion and 236 nsSNPs (52%) are tolerated. Subsequently, SIFT analy-R154G 2
R389G
Rs118204011 L108F Non-synonymous 2
L343F
Rs118204012 E160G Non-synonymous 2
E189G
Rs28934605 G96E Non-synonymous 2
G125E




Rs28934607 P147S Non-synonymous 2
P382S
Rs568165894 R429H Non-synonymous 1
R429P Non-synonymous 1
Rs759208930 R453H Non-synonymous 1
Data derived from PROVEAN [1].
Table 4
PolyPhen-2 analysis of Pathogenic coding nsSNPs in human CYP27B1.
Replacement Effect Score Sensitivity Specificity
G73E Probably Damaging 1.000 0.00 1.00
G102E Probably Damaging 0.989 0.72 0.97
T321R Probably Damaging 1.000 0.00 1.00
T409I Benign 0.004 0.97 0.59
R154C Probably Damaging 1.000 0.00 1.00
L343F Probably Damaging 1.000 0.00 1.00
E189G Probably Damaging 0.984 0.74 0.96
G125E Probably Damaging 1.000 0.00 1.00
R335P Probably Damaging 0.994 0.69 0.97
R335Q Possibly Damaging 0.610 0.87 0.91
P147S Probably Damaging 0.994 0.69 0.97
P382S Probably Damaging 0.999 0.14 0.99
R429H Benign 0.065 0.94 0.84
R429P Probably Damaging 0.976 0.76 0.96
R453H Probably Damaging 1.000 0.00 1.00
Data derived from Poly-Phen 2 [9].
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of 11 nsSNPs (3%) and ‘tolerated-low confidence’ of 11 nsSNPs (2%).
The nsSNP Analyzer, which was used to predict the clinical signif-
icance of SNPs from human CYP27B1 predicted that 24 nsSNPs
(55%) are pathogenic or disease causing, 4 nsSNPs (9%) are ‘likely
pathogenic’, and 16 nsSNPs (36%) having uncertain significance.
nsSNPs without any clinical significance were left blank.Table 5
Conservation profile of amino acids in CYP27B1.





rs118204007 T321 9 Highly conserved and exposed (f)
rs118204008 T409 8 Buried
rs118204010 R389 9 Highly conserved and exposed (f)
rs118204011 L343 8 Buried
rs118204012 E189 5 Exposed
rs28934605 G125 9 Highly conserved and buried (s)





Highly conserved and exposed (f)
Highly conserved and exposed (f)
rs568165894 R429 1 Exposed
rs759208930 R453 9 Highly conserved and exposed (f)
Data obtained from ConSurf [10]/
Fig. 2. Results from the Analysis of humaDifferent in silico techniques used different algorithms, resulting
in often considerable difference in results. Thusberg and Vihinen
[24] reviewed these tools and suggested that SIFT and PolyPhen-
2 have better performance in identifying deleterious nsSNPs. This
observation was validated by Hicks et al. [25] and this makes these
tools useful for our study. However, nsSNPs with greater confi-
dence were expected to be truly deleterious. At this point, high-
risk nsSNPs were classified based on their predicted pathogenicity
or disease related prediction by the algorithms. Twenty-four
nsSNPs in human CYP27B1 met these conditions and were care-
fully selected for extra examination as shown in Table 3. This group
was then analysed further with PolyPhen-2 as well as PROVEN,
ConSurf and I-Mutant. The PROVEN analysis identified 11 to be
responsible for deleterious amino acid substitution.
In particular, PolyPhen-2 results showed that nine amino acid
switches (G73E, G102E, T321R, R154C, L343F, E189G, G125E,
R335P, P147S, P382S, R429P and R453H) were recorded as proba-
bly damaging (score > 0.96), 1 amino acid substitution (R335Q)
was noted as possibly damaging (score >0.2 and <0.96), and 2
amino acid substitutions (T409I and R429H) was scored as benign
(score < 0.2) (Table 4).3.3. High-risk non-synonymous SNPs conservation profile
Several significant biological processes constantly involve the
presence of amino acids; either being present in catalytic sites orn CYP27B1 protein by ConSurf [10].
Table 6
Schematic structures of the original (left) and mutant (right) amino acid for each Mutation.
Residue Structure Properties
G73E - the mutant residue is bigger than the wild-type residue.
- the wild-type residue is charged neutral; the mutant residue is charged negative.
- the wild-type reside is more hydrophobic than the mutant residue.
- the wild type residue is much conserved; the mutant residue is located near a highly
conserved position.
G102E - the mutant residue is bigger than the wild-type residue
- the wild-type residue is charged neutral, the mutant residue is charged negative
- the wild-type reside is more hydrophobic than the mutant residue.
- the wild type residue is much conserved, the mutant residue is located near a highly
conserved position
T321R - the mutant residue is bigger than the wild-type residue
- the wild-type residue is charged neutral, the mutant residue is charged positive
- the wild-type reside is more hydrophobic than the mutant residue.
- the wild type residue is much conserved, the mutant residue is located near a highly
conserved position
T409I - the mutant residue is bigger than the wild-type residue
- the wild-type reside is more hydrophobic than the mutant residue.
- the wild type residue is not conserved, the mutant residue is among the observed resi-
due types at this position.
R389C - the mutant residue is smaller than the wild-type residue
- the wild-type residue is charged positive, the mutant residue is charged neutral.
- the wild-type reside is more hydrophobic than the mutant residue.
- the wild type residue is very conserved, the mutant residue was not observed at this
position.
R389G - the mutant residue is smaller than the wild-type residue
- the wild-type residue is charged positive, the mutant residue is charged neutral.
- the wild-type reside is more hydrophobic than the mutant residue.
- the wild type residue is very conserved, the mutant residue was not observed at this
position.
(continued on next page)
S.O. Rotimi et al. / The Egyptian Journal of Medical Human Genetics 19 (2018) 367–378 371
Table 6 (continued)
Residue Structure Properties
L343F - the mutant residue is bigger than the wild-type residue
- the wild type residue is very conserved, the mutant residue was not observed at this
position.
E189G - the mutant residue is smaller than the wild-type residue
- the wild-type residue is charged negative, the mutant residue is charged neutral
- the wild-type reside is more hydrophobic than the mutant residue
G125E - the mutant residue is bigger than the wild-type residue
- the wild-type residue is charged neutral, the mutant residue is charged negative
- the wild-type reside is more hydrophobic than the mutant residue.
- the mutant and wild-type residue are not very similar. based on this conservation infor-
mation, this mutation is probably damaging to the protein.
R335P - the mutant residue is smaller than the wild-type residue
- the wild-type residue is charged positive, the mutant residue is charged neutral.
- the wild-type reside is more hydrophobic than the mutant residue.
- the wild type residue is observed alongside other residues, the mutant residue was not
observed at this position.
R335Q - the mutant residue is smaller than the wild-type residue
- the wild-type residue is charged positive, the mutant residue is charged neutral.
- the wild type residue is observed alongside other residues; the mutant residue was also
observed amongst other residues at this position. This means the mutation can occur at
this position and is probably not damaging to the protein.
R429H - the mutant residue is smaller than the wild-type residue
- the wild-type residue is charged positive, the mutant residue is charged neutral.
- the wild type residue is not conserved at this region,
- the mutant residue is located near a highly conserved position.
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Table 6 (continued)
Residue Structure Properties
R429P - the mutant residue is smaller than the wild-type residue
- the wild-type residue is charged positive, the mutant residue is charged neutral.
- the wild-type reside is more hydrophobic than the mutant residue
- the wild type residue is not conserved at this region,
- the mutant residue is located near a highly conserved position.
R453H - the mutant residue is smaller than the wild-type residue
- the wild-type residue is charged positive, the mutant residue is charged neutral.
- the wild type residue is very conserved at this region, but a few other residue types have
been observed at this position too,
- the mutant residue was not observed at this position or any position. this mutation is
probably damaging to the protein.
Data obtained from project HOPE [18].
Table 7
MutPred analysis of amino acid substitutions related to diseases and phenotypes.
SNPs Actionable/Confident Hypothesis MutPred2 score p-value
G73E Altered DNA binding 0.914 0.03
Altered Transmembrane protein 0.03
G102E Gain of Intrinsic disorder 0.702 0.03
Gain of B-factor 0.02
T321R Altered Metal binding 0.954 1.40E03
Gain of Helix 0.02
Loss of Loop 0.01
Altered Transmembrane protein 3.90E03
Gain of Allosteric site at T321 0.04
Loss of Catalytic site at D320 0.04
Loss of GPI-anchor amidation at N324 0.03
T409I Altered Ordered interface 0.558 7.40E03
Altered Metal binding 0.05
R389G Loss of Allosteric site at R389 0.958 4.90E06
Altered Ordered interface 5.70E04
Altered Metal binding 0.01
Loss of Catalytic site at R389 7.00E03
Gain of Ubiquitylation at K393 0.02
Altered Transmembrane protein 0.02
Altered Stability 0.12
Gain of GPI-anchor amidation at N387 0.02
L343F None 0.487 –
E189G Loss of Acetylation at K192 0.775 0.02
Gain of Intrinsic disorder 0.04
Loss of Loop 0.91 0.02
Gain of Strand 0.03
R335P Altered Metal binding 0.727 5.90E03
R335Q None 0.19 –
R429H None 0.064 –
R429P None 0.47
R453H Altered Metal binding 0.893 0.01
Loss of Catalytic site at R453 2.00E03
Loss of Allosteric site at R453 4.90E03
Loss of Helix 0.04
Loss of Acetylation at K452 0.01
Altered DNA binding 0.05
Data obtained from MutPred [13].
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Table 9
I-Mutant results for carefully chosen nsSNPs in the CYP27B1 gene.
nsSNP ID Mutation DDG Sign of DDG
rs1057520815 G73E 0.25 Increase (3)
G102E 0.30 Increase (4)
rs118204007 T86R 1.46 Decrease (9)
T321R 0.37 Decrease (2)
rs118204008 T409I 0.44 Decrease (6)
rs118204010 R154C 1.05 Decrease (3)
R389G 1.50 Decrease (8)
rs118204011 L108F 0.03 Increase (1)
L343F 0.87 Decrease (5)
rs118204012 E160G 1.27 Decrease (9)
E189G 1.46 Decrease (9)
rs28934605 G125E 0.30 Decrease (2)
rs28934606 R335P 0.34 Decrease (4)
R100Q 0.40 Decrease (2)
R335Q 0.66 Decrease (7)
rs28934607 P147S 0.82 Decrease (8)
P382S 1.55 Decrease (8)
rs568165894 R429H 1.11 Decrease (8)
R429P 0.59 Decrease (5)
rs759208930 R453H 1.30 Decrease (9)
Data obtained from I-Mutant [15].
Table 8
nsSNPs analysis by ModPred.
Residue Modification Score Confidence Remarks
T409I Proteolytic Cleavage 0.54 Low Novel Prediction
R389C ADP-Ribosylation 0.67 Medium Novel Prediction
R389G Proteolytic Cleavage 0.58 Low Novel Prediction
E189G Proteolytic Cleavage 0.58 Low Novel Prediction
G125E Proteolytic Cleavage 0.58 Low Novel Prediction
R335P ADP-Ribosylation 0.67 Medium Novel Prediction
R335Q ADP-Ribosylation 0.67 Medium Novel Prediction
R429H ADP-Ribosylation 0.60 Low Novel Prediction
R429P ADP-Ribosylation 0.60 Low Novel Prediction
R453H Proteolytic Cleavage 0.78 Medium Novel Prediction
Data obtained from ModPred [39].
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amino acids lean towards being more conserved than other resi-
dues. NsSNPs situated at extremely conserved amino acid locations
are more deleterious than nsSNPs at non-conversed locations. For
advance examination of the possible effects of the high-risk
nsSNPs, the degree of evolutionary conservation was calculated
using the ConSurf web server for amino acids human CYP27B1 pro-
tein [10]. For this study, there was more concentration on amino
acid sites that match locations where the high-risk nsSNPs are pre-
sent; however, ConSurf also acknowledges some other residues
that may have purposeful significance.
As presented in Table 5 and Fig. 2, ConSurf analysis revealed
that residues G73, T321, T409, R389, L343, G125, P382, R453 are
highly conserved (Conservation Score of 7–9) and predicted less
conserved residues E189, R429 which were exposed (Conservation
Score of 5). Furthermore, ConSurf prediction gave G125 as highly
conserved and buried, which makes it an important structural resi-
due, and that T321, R389, P382, R453 were functionally significant
residues (highly conserved and exposed). The location of the highly
conserved residues to the protein surface or protein core helps in
predicting their structural or functional base. Interestingly, five of
the high-risk nsSNPs that were predicted to be deleterious by the
SNP prediction algorithms (P382, R453, R389, T321 and G125)
were also recognized as significant structural or functional resi-
dues by ConSurf. Our data strongly backs up the claim that these
nsSNPs are deleterious to CYP27B1 structure and/or function.
Furthermore, the project HOPE was used to investigate the
structural effects of these amino acid substitutions. Its resultsshowed that T321, R389 and G125 are highly conserved and their
substitutions are probably damaging to the protein structure. It is
noteworthy that the germline mutation at these positions have
been reported to be responsible for abolishing enzymatic activity
of CYP27B1 leading to Vitamin D-dependent hereditary rickets
type 1 [5,26–28]. For example, the R389G mutation is a change
to smaller amino acid while T321R and G125E, were changes to
amino acid bigger than the residue in wild type. All the three sub-
stitution resulted in change in the net charge of CYP27B1 protein
(Table 6). It is known that protein charge and mass affect spatio-
temporal dynamics of protein-protein interaction [29,30]; hence,
these changes could alter the ability of CYP27B1 to interact the
other proteins.3.4. Identification of disease phenotype related with nsSNPs in human
CYP27B1
Phenotypic analysis of the amino acid replacements accounted
as ‘pathogenic’ was done using MutPred. The MutPred is a web-
tool that predicts diseased phenotype and also identifies the
molecular mechanisms that result from amino acid replacement
instigated by nsSNPs. Subsequently, valuable data such as addition
or loss of solvent accessibility is also provided by MutPred. The g-
value and p-value scores of the amino acid substitution are shown
in Table 7. A g-value score greater than 0.5 and p-value scores less
than 0.05 are referred to as actionable hypotheses, whereas the
scores with g-value greater than 0.75 and p-value less than 0.05
are referred to as confident hypotheses. Of interest were the muta-
tions of T321R, R389G and G125E, which were associated with
altered metal binding, loss of allosteric site and gain of intrinsic
disorder, respectively.3.5. Prediction of post translational modification sites for human
CYP27B1 protein
ModPred tool was used to analyse the effect of nsSNPs on post
translational modification process in human CYP27B1 protein.
ModPred predicted sites for proteolytic cleavage and ADP-
Ribosylation as presented in Table 8.
The mutations at these conserved locations affect the posttrans-
lational modification of the protein; particularly, R389C and G125E
could result in the loss of ADP-ribosylation and proteolytic cleav-
age respectively. The loss of posttranslational modification sites
has deleterious clinical implications. For example, ADP-
ribosylation is involved in cellular processes like cell signalling
and apoptosis, and its alteration has been implicated in carcino-
genesis [31]. It is therefore possible that these mutations could
account for alteration on vitamin D signalling that has been
reported in some cancer [32–34].
Fig. 4. Modelled 3D structure of CYP25B1. The positions of mutation with significant disease-related phenotypes are indicated in red, as generated from SWISS-MODEL [19].
Fig. 3. Secondary structure of CYP27B1 showing beta helix, strand and coil. The results highlight a mix distribution of coil, alpha helix and strands. The coil was observed to be
the major secondary structural motif among various structural elements (51%), followed by helix (35%) and strand (7%), as generated by PSIPRED [14].
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interaction of human CYP27B1
There is a consensus that most diseases associated with nsSNPs
affect the protein stability. The effect of mutation on the human
CYP27B1 protein stability was investigated using the I-Mutant ser-
ver. I-Mutant utilizes the structure based analysis of the mutant
protein to deliver an estimate of the free energy change in mutant
protein with amino acid replacement at a single location (Table 9).
The I-Mutant results indicated that almost all the amino acid sub-
stitution studied will decrease the degree of free energy change
value of the protein.
The predicted tertiary structure of CYP27B1 protein showed
that all the amino acid substitutions investigated resulted in vary-
ing degrees of disruption to the tertiary structure of CYP27B1Fig. 5. Protein–protein interaction network of CYP27B1 protein shown by STRING. STRIN
using STRING [20].
Table 10












Data generated from SWISS-MODEL [40].(Figs. 3 and 4 and Table 10). For example, T321R and R389G would
decrease the solvation and increase torsion of CYP28B1. Protein
solvation and torsion are known to affect the energetically favour-
able conformation and chain elasticity of proteins [35] and they are
used to predict the stability of mutant proteins [36]. These physical
changes to the protein structure consequently affects the molecu-
lar interaction ability of its side chains [36].
Optimum protein-protein interaction is important to allow for
metabolite interaction and maintenance of normal cellular func-
tion [29]. However, it is worthy of note that protein-protein inter-
action occurs at the level of protein tertiary structure and this
makes it important to predict the impact of nsSNPs on tertiary
structure of CYP27B1.
Therefore, these pathogenic mutations in the human CYP27B1
could result in altered stability and metal binding, as well as lossG database is used to predict functional interaction between the proteins in the cell,
1.











S.O. Rotimi et al. / The Egyptian Journal of Medical Human Genetics 19 (2018) 367–378 377of allosteric and catalytic residue with a concomitant loss of
enzyme activity. Furthermore, we used the STRING maps to inves-
tigate the protein–protein interaction of CYP27B1 (Fig. 5). This is
useful in understanding the genotype-phenotype consequence of
the mutation [37].
STRING database was used to predict functional interaction
between the proteins in the cell. STRING results predicted the func-
tional association partner of CYP27B1 protein with CYP24A1 (Cyto-
chrome P450, family 24, subfamily A, polypeptide 1), CALCA
(Calcitonin-related polypeptide alpha), FGF23 (Fibroblast growth
factor 23), PTH (Parathyroid hormone), VDR (Vitamin D (1, 25-
dihydroxyvitamin D3) receptor; Nuclear hormone receptor), TLR2
(Toll-like receptor 2), CYP2R1 (Cytochrome P450, family 2, subfam-
ily R, polypeptide 1), POR (P450 (cytochrome) oxidoreductase),
PPIG (Peptidylprolyl isomerase G (cyclophilin G)) and AHR (Aryl
hydrocarbon receptor; Ligand-activated transcriptional activator).
Out of these proteins, CYP24A1, CYP2R1 and VDR directly affect
the level of circulating synthesis and actions of 1-a, 25 dihydrox-
yvitamin D3. This shows that the consequence of CYP27B1 muta-
tion could affect other proteins involved in vitamin D
metabolism and function.4. Conclusion
Out of the 411 nsSNPs found in human CYP27B1, 11 have signif-
icant disease related phenotype. Out of these, three-rs118204007,
rs118204010 and rs28934605 affect conserved positions. The
amino acid substitutions R389C and G125E affect posttranslational
modification sites. These mutations can consequently affect the
function of CYP27B1 resulting in vitamin D deficiency or insuffi-
ciency; thereby, leading to diverse pathological conditions like
rickets, diabetes and various cancer.References
[1] Dakal TC, Kala D, Dhiman G, Yadav V, Krokhotin A, Dokholyan NV. Predicting
the functional consequences of non-synonymous single nucleotide
polymorphisms in IL8 gene. Sci Rep 2017;7(1):6525. doi: https://doi.org/
10.1038/s41598-017-06575-4. PubMed PMID: 28747718; PubMed Central
PMCID: PMCPMC5529537.
[2] Sawada N, Sakaki T, Kitanaka S, Takeyama K, Kato S, Inouye K. Enzymatic
properties of human 25-hydroxyvitamin D3 1alpha-hydroxylase coexpression
with adrenodoxin and NADPH-adrenodoxin reductase in Escherichia coli. Eur J
Biochem 1999;265(3):950–6. PubMed PMID: 10518789.
[3] Holick MF. Vitamin D status: measurement, interpretation, and clinical
application. Ann Epidemiol 2009;19(2):73–8. doi: https://doi.org/10.1016/j.
annepidem.2007.12.001. PubMed PMID: 18329892; PubMed Central PMCID:
PMCPMC2665033.
[4] Holick MF. Vitamin D: the other steroid hormone for muscle function and
strength. Menopause 2009;16(6):1077–8. doi: https://doi.org/10.1097/
gme.0b013e3181bd9804. PubMed PMID: 19801955.
[5] Kato S, Yanagisawa J, Murayama A, Kitanaka S, Takeyama K. The importance of
25-hydroxyvitamin D3 1 alpha-hydroxylase gene in vitamin D-dependent
rickets. Curr Opin Nephrol Hypertens 1998;7(4):377–83. PubMed PMID:
9690035.
[6] Ahmad S, Chowdhury TA, Boucher BJ. Diabetes and cancer: could vitamin D
provide the link? J Diabetes Complications 2013;27(2):184–90. doi: https://
doi.org/10.1016/j.jdiacomp.2012.10.005. PubMed PMID: 23164631.
[7] Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, et al. dbSNP:
the NCBI database of genetic variation. Nucl Acids Res 2001;29(1):308–11.
PubMed PMID: 11125122; PubMed Central PMCID: PMCPMC29783.
[8] Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A
method and server for predicting damaging missense mutations. Nat Meth
2010;7(4):248–9. doi: https://doi.org/10.1038/nmeth0410-248. PubMed
PMID: 20354512; PubMed Central PMCID: PMCPMC2855889.
[9] Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous
variants on protein function using the SIFT algorithm. Nat Protoc 2009;4
(7):1073–81. doi: https://doi.org/10.1038/nprot.2009.86. PubMed PMID:
19561590.
[10] Ashkenazy H, Erez E, Martz E, Pupko T, Ben-Tal N, et al. ConSurf 2010:
calculating evolutionary conservation in sequence and structure of proteins
and nucleic acids. Nucl Acids Res 2010;38(Web Server issue). pp. W529-33,
doi: 10.1093/nar/gkq399. PubMed PMID: 20478830; PubMed Central PMCID:
PMCPMC2896094.[11] Mayrose I, Graur D, Ben-Tal N, Pupko T. Comparison of site-specific rate-
inference methods for protein sequences: empirical Bayesian methods are
superior. Mol Biol Evol 2004;21(9):1781–91. doi: https://doi.org/
10.1093/molbev/msh194. PubMed PMID: 15201400.
[12] Pupko T, Bell RE, Mayrose I, Glaser F, Ben-Tal N. Rate4Site: an algorithmic tool
for the identification of functional regions in proteins by surface mapping of
evolutionary determinants within their homologues. Bioinformatics 2002;18
(Suppl 1):S71–7. PubMed PMID: 12169533.
[13] Li B, Krishnan VG, Mort ME, Xin F, Kamati KK, Cooper DN, et al. Automated
inference of molecular mechanisms of disease from amino acid substitutions.
Bioinformatics 2009;25(21):2744–50. doi: https://doi.org/10.1093/
bioinformatics/btp528. PubMed PMID: 19734154; PubMed Central PMCID:
PMCPMC3140805.
[14] Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped
BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucl Acids Res 1997;25(17):3389–402. PubMed PMID: 9254694; PubMed
Central PMCID: PMCPMC146917.
[15] Capriotti E, Calabrese R, Casadio R. Predicting the insurgence of human genetic
diseases associated to single point protein mutations with support vector
machines and evolutionary information. Bioinformatics 2006;22
(22):2729–34. doi: https://doi.org/10.1093/bioinformatics/btl423. PubMed
PMID: 16895930.
[16] Mavroconstanti T, Johansson S, Winge I, Knappskog PM, Haavik J. Functional
properties of rare missense variants of human CDH13 found in adult attention
deficit/hyperactivity disorder (ADHD) patients. PLoS One 2013;8(8):e71445.
doi: https://doi.org/10.1371/journal.pone.0071445. PubMed PMID: 23936508;
PubMed Central PMCID: PMCPMC3731280.
[17] Pejaver RK, Nisarga R, Gowda B. Temperature monitoring in newborns using
thermospot. Indian J Pediatr 2004;71(9):795–6. PubMed PMID: 15448385.
[18] Venselaar H, Te BeekA, Kuipers RK, Hekkelman ML, Vriend G. Protein structure
analysis of mutations causing inheritable diseases. An e-Science approach with
life scientist friendly interfaces. BMC Bioinf 2010;11:548. doi: https://doi.org/
10.1186/1471-2105-11-548. PubMed PMID: 21059217; PubMed Central
PMCID: PMCPMC2992548.
[19] Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, et al. SWISS-
MODEL: modelling protein tertiary and quaternary structure using
evolutionary information. Nucl Acids Res 2014;42(Web Server issue). pp.
W252-8, doi: 10.1093/nar/gku340. PubMed PMID: 24782522; PubMed Central
PMCID: PMCPMC4086089.
[20] Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, et al.
The STRING database in 2011: functional interaction networks of proteins,
globally integrated and scored. Nucl Acids Res 2011;39(Database issue). pp.
D561-8, doi: 10.1093/nar/gkq973. PubMed PMID: 21045058; PubMed Central
PMCID: PMCPMC3013807.
[21] Jacobs ET, Van Pelt C, Forster RE, Zaidi W, Hibler EA, Galligan MA, et al.
CYP24A1 and CYP27B1 polymorphisms modulate vitamin D metabolism in
colon cancer cells. Cancer Res 2013;73(8):2563–73. doi: https://doi.org/
10.1158/0008-5472.CAN-12-4134. PubMed PMID: 23423976; PubMed
Central PMCID: PMCPMC3630267.
[22] Lopez ER, Regulla K, Pani MA, Krause M, Usadel KH, Badenhoop K. CYP27B1
polymorphisms variants are associated with type 1 diabetes mellitus in
Germans. J Steroid BiochemMol Biol 2004;89–90(1–5):155–7. doi: https://doi.
org/10.1016/j.jsbmb.2004.03.095. PubMed PMID: 15225764.
[23] Agnello L, Scazzone C, Lo Sasso B, Bellia C, Bivona G, Realmuto S, et al. VDBP,
CYP27B1, and 25-Hydroxyvitamin D Gene Polymorphism Analyses in a Group
of Sicilian Multiple Sclerosis Patients. Biochem Genet 2017;55(2):183–92. doi:
https://doi.org/10.1007/s10528-016-9783-4. PubMed PMID: 27904983.
[24] Thusberg J, Vihinen M. Pathogenic or not? And if so, then how? Studying the
effects of missense mutations using bioinformatics methods. Hum Mutat
2009;30(5):703–14. doi: https://doi.org/10.1002/humu.20938. PubMed PMID:
19267389.
[25] Hicks S, Wheeler DA, Plon SE, Kimmel M. Prediction of missense mutation
functionality depends on both the algorithm and sequence alignment
employed. Hum Mutat 2011;32(6):661–8. doi: https://doi.org/10.1002/
humu.21490. PubMed PMID: 21480434; PubMed Central PMCID:
PMCPMC4154965.
[26] Kato S. Genetic mutation in the human 25-hydroxyvitamin D3 1alpha-
hydroxylase gene causes vitamin D-dependent rickets type I. Mol Cell
Endocrinol 1999;156(1–2):7–12. PubMed PMID: 10612418.
[27] Kitanaka S, Murayama A, Sakaki T, Inouye K, Seino Y, Fukumoto S, et al. No
enzyme activity of 25-hydroxyvitamin D3 1alpha-hydroxylase gene product in
pseudovitamin D deficiency rickets, including that with mild clinical
manifestation. J Clin Endocrinol Metab 1999;84(11):4111–7. doi: https://doi.
org/10.1210/jcem.84.11.6131. PubMed PMID: 10566658.
[28] Kitanaka S, Takeyama K, Murayama A, Sato T, Okumura K, Nogami M, et al.
Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene
in patients with pseudovitamin D-deficiency rickets. N Engl J Med 1998;338
(10):653–61. doi: https://doi.org/10.1056/NEJM199803053381004. PubMed
PMID: 9486994.
[29] Xu Y, Wang H, Nussinov R, Ma B. Protein charge and mass contribute to the
spatio-temporal dynamics of protein-protein interactions in a minimal
proteome. Proteomics 2013;13(8):1339–51. doi: https://doi.org/10.1002/
pmic.201100540. PubMed PMID: 23420643; PubMed Central PMCID:
PMCPMC3762602.
[30] Peleg O, Choi JM, Shakhnovich EI. Evolution of specificity in protein-protein
interactions. Biophys J 2014;107(7):1686–96. doi: https://doi.org/10.1016/j.
378 S.O. Rotimi et al. / The Egyptian Journal of Medical Human Genetics 19 (2018) 367–378bpj.2014.08.004. PubMed PMID: 25296322; PubMed Central PMCID:
PMCPMC4190652.
[31] Scarpa ES, Fabrizio G, Di Girolamo M. A role of intracellular mono-ADP-
ribosylation in cancer biology. FEBS J 2013;280(15):3551–62. doi: https://doi.
org/10.1111/febs.12290. PubMed PMID: 23590234.
[32] Chen TC. 25-Hydroxyvitamin D-1 alpha-hydroxylase (CYP27B1) is a new class
of tumor suppressor in the prostate. Anticancer Res 2008;28(4A):2015–7.
PubMed PMID: 18649741.
[33] Kang W, Lee S, Jeon E, Yun YR, Kim KH, Jang JH. Emerging role of vitamin D in
colorectal cancer. World J Gastrointest Oncol 2011;3(8):123–7. doi: https://
doi.org/10.4251/wjgo.v3.i8.123. PubMed PMID: 22007275; PubMed Central
PMCID: PMCPMC3192221.
[34] Gupta D, Vashi PG, Trukova K, Lis CG, Lammersfeld CA. Prevalence of serum
vitamin D deficiency and insufficiency in cancer: review of the epidemiological
literature. Exp Ther Med 2011;2(2):181–93. doi: https://doi.org/10.3892/
etm.2011.205. PubMed PMID: 22977487; PubMed Central PMCID:
PMCPMC3440651.
[35] Sorokina I, Mushegian A. The role of the backbone torsion in protein folding.
Biol Direct 2016;11(1):64. doi: https://doi.org/10.1186/s13062-016-0166-x.
PubMed PMID: 27906033; PubMed Central PMCID: PMCPMC5133741.
[36] Parthiban V, Gromiha MM, Hoppe C, Schomburg D. Structural analysis and
prediction of protein mutant stability using distance and torsion potentials:role of secondary structure and solvent accessibility. Proteins 2007;66
(1):41–52. doi: https://doi.org/10.1002/prot.21115. PubMed PMID: 17068801.
[37] Mohamoud HS, Hussain MR, El-Harouni AA, Shaik NA, Qasmi ZU, Merican AF,
et al. First comprehensive in silico analysis of the functional and structural
consequences of SNPs in human GalNAc-T1 gene. Comput Math Methods Med.
2014;2014:904052. doi: https://doi.org/10.1155/2014/904052. PubMed
PMID: 24723968; PubMed Central PMCID: PMCPMC3960557.
[38] Zerbino DR, Achuthan P, Akanni W, Amode MR, Barrell D, Bhai J, et al. Ensembl
2018. Nucl Acids Res 2018;46(D1). doi: https://doi.org/10.1093/nar/gkx1098.
PubMed PMID: 29155950; PubMed Central PMCID: PMCPMC5753206. D754-
D61.
[39] Pejaver V, Hsu WL, Xin F, Dunker AK, Uversky VN, Radivojac P. The structural
and functional signatures of proteins that undergo multiple events of post-
translational modification. Protein Sci 2014;23(8):1077–93. doi: https://doi.
org/10.1002/pro.2494. PubMed PMID: 24888500; PubMed Central PMCID:
PMCPMC4116656.
[40] Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL workspace: a web-
based environment for protein structure homology modelling. Bioinformatics
2006;22(2):195–201. doi: https://doi.org/10.1093/bioinformatics/bti770.
PubMed PMID: 16301204.
